Cargando…
Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure
Cell transplantation to repair or regenerate injured myocardium is a new frontier in the treatment of cardiovascular disease. Even though it is based on many years of pre-clinical studies, much remains to be understood about this methodology, even as it progresses to the clinic. For example, controv...
Autor principal: | Taylor, Doris A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59528/ https://www.ncbi.nlm.nih.gov/pubmed/11806797 http://dx.doi.org/10.1186/cvm-2-5-208 |
Ejemplares similares
-
Cellular Cardiomyoplasty and Cardiac Regeneration
por: Pendyala, Lakshmana, et al.
Publicado: (2008) -
New Approaches in Heart Research: Prevention Instead of Cardiomyoplasty?
por: Gaebel, Ralf, et al.
Publicado: (2023) -
Nine-year follow-up of local implantation of autologous skeletal myoblasts in a patient with coronary heart disease
por: Zhang, Dingguo, et al.
Publicado: (2013) -
NF-E2-related factor 2 over-expression in mesenchymal stem cells to improve cellular cardiomyoplasty
por: Mohammadzadeh-Vardin, Mohammad, et al.
Publicado: (2014) -
Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion
por: Anastasiadis, Kyriakos, et al.
Publicado: (2011)